|
|
News Breaks | | | | December 14, 2012 | | 13:04 EDT |  | AZN, TEVA, MYL | Court backs AstraZeneca, blocks generic Crestor, Bloomberg reports
A U.S. appeals court ruled in favor of AstraZeneca (AZN), saying its patent on Crestor is valid and enforceable and rejecting challenges made by generic-drug makers including Mylan (MYL) and Teva Pharmaceuticals (TEVA), reported Bloomberg. The ruling protects the valuable cholesterol medicine, which brought in $2.3B in revenue in the first nine months of this year in the U.S., the report noted. Reference Link | |
|
News For AZN;MYL;TEVA From The Last 14 Days Check below for free stories on AZN;MYL;TEVA the last two weeks. |
|
|
| There are no results for AZN;MYL;TEVA |
|
|
|
|
|
|
